379 related articles for article (PubMed ID: 9843792)
1. Heart and lung VEGF mRNA expression in rats with monocrotaline- or hypoxia-induced pulmonary hypertension.
Partovian C; Adnot S; Eddahibi S; Teiger E; Levame M; Dreyfus P; Raffestin B; Frelin C
Am J Physiol; 1998 Dec; 275(6):H1948-56. PubMed ID: 9843792
[TBL] [Abstract][Full Text] [Related]
2. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
[TBL] [Abstract][Full Text] [Related]
3. Increased vascular endothelial growth factor production in the lungs of rats with hypoxia-induced pulmonary hypertension.
Christou H; Yoshida A; Arthur V; Morita T; Kourembanas S
Am J Respir Cell Mol Biol; 1998 Jun; 18(6):768-76. PubMed ID: 9618381
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.
Voelkel NF; Tuder RM; Bridges J; Arend WP
Am J Respir Cell Mol Biol; 1994 Dec; 11(6):664-75. PubMed ID: 7946395
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor expression in heart of rats exposed to hypobaric hypoxia: differential response between mRNA and protein.
Birot OJ; Peinnequin A; Simler N; van Cuyck-Gandré H; Hamel R; Bigard XA
J Cell Physiol; 2004 Jul; 200(1):107-15. PubMed ID: 15137063
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
[TBL] [Abstract][Full Text] [Related]
7. Prolonged inhaled NO attenuates hypoxic, but not monocrotaline-induced, pulmonary vascular remodeling in rats.
Horstman DJ; Frank DU; Rich GF
Anesth Analg; 1998 Jan; 86(1):74-81. PubMed ID: 9428855
[TBL] [Abstract][Full Text] [Related]
8. Right Ventricle Remodeling Metabolic Signature in Experimental Pulmonary Hypertension Models of Chronic Hypoxia and Monocrotaline Exposure.
Hautbergue T; Antigny F; Boët A; Haddad F; Masson B; Lambert M; Delaporte A; Menager JB; Savale L; Pavec JL; Fadel E; Humbert M; Junot C; Fenaille F; Colsch B; Mercier O
Cells; 2021 Jun; 10(6):. PubMed ID: 34205639
[TBL] [Abstract][Full Text] [Related]
9. Altered mTOR and Beclin-1 mediated autophagic activation during right ventricular remodeling in monocrotaline-induced pulmonary hypertension.
Deng Y; Wu W; Guo S; Chen Y; Liu C; Gao X; Wei B
Respir Res; 2017 Mar; 18(1):53. PubMed ID: 28340591
[TBL] [Abstract][Full Text] [Related]
10. [Hypoxia-inducible factor 1alpha regulates vascular endothelial growth factor's roles on pulmonary arteries of rats with hypoxia-induced pulmonary hypertension].
Li QF; Dai AG
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Mar; 27(3):174-8. PubMed ID: 15130328
[TBL] [Abstract][Full Text] [Related]
11. Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension.
Campbell AI; Zhao Y; Sandhu R; Stewart DJ
Circulation; 2001 Oct; 104(18):2242-8. PubMed ID: 11684638
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine protects against monocrotaline-induced pulmonary arterial remodeling by inhibition of hypoxia-inducible factor-1α and vascular endothelial growth factor.
Han DD; Wang Y; Zhang XH; Liu JR; Wang HL
Can J Physiol Pharmacol; 2012 Apr; 90(4):445-54. PubMed ID: 22448962
[TBL] [Abstract][Full Text] [Related]
13. [Changes of the gene expression of vascular endothelial growth factor in the lung of rats with chronic hypoxic pulmonary hypertension].
Chen W; Cheng D; Wu Q
Hua Xi Yi Ke Da Xue Xue Bao; 1998 Sep; 29(3):233-6. PubMed ID: 10684080
[TBL] [Abstract][Full Text] [Related]
14. Cardiac and lung VEGF mRNA expression in chronically hypoxic and monocrotaline-treated rats.
Partovian C; Ladoux A; Eddahibi S; Teiger E; Raffestin B; Frelin C; Adnot S
Chest; 1998 Jul; 114(1 Suppl):45S-46S. PubMed ID: 9676624
[No Abstract] [Full Text] [Related]
15. Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats.
Ito T; Zhang E; Omori A; Kabwe J; Kawai M; Maruyama J; Okada A; Yokochi A; Sawada H; Mitani Y; Maruyama K
BMC Pulm Med; 2021 Nov; 21(1):377. PubMed ID: 34801000
[TBL] [Abstract][Full Text] [Related]
16. Chronic hypoxia- and monocrotaline-induced elevation of hypoxia-inducible factor-1 alpha levels and pulmonary hypertension.
Lai YL; Law TC
J Biomed Sci; 2004; 11(3):315-21. PubMed ID: 15067214
[TBL] [Abstract][Full Text] [Related]
17. Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats.
Lourenço AP; Roncon-Albuquerque R; Brás-Silva C; Faria B; Wieland J; Henriques-Coelho T; Correia-Pinto J; Leite-Moreira AF
Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1587-94. PubMed ID: 16679394
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of GLUT-4 in right ventricle of rats with monocrotaline-induced pulmonary hypertension.
Broderick TL; King TM
Med Sci Monit; 2008 Dec; 14(12):BR261-4. PubMed ID: 19043358
[TBL] [Abstract][Full Text] [Related]
19. Time course and mechanisms of left ventricular systolic and diastolic dysfunction in monocrotaline-induced pulmonary hypertension.
Correia-Pinto J; Henriques-Coelho T; Roncon-Albuquerque R; Lourenço AP; Melo-Rocha G; Vasques-Nóvoa F; Gillebert TC; Leite-Moreira AF
Basic Res Cardiol; 2009 Sep; 104(5):535-45. PubMed ID: 19288153
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of matricellular proteins in hypertrophied right ventricle of monocrotaline-induced pulmonary hypertensive rats.
Imoto K; Okada M; Yamawaki H
J Vet Med Sci; 2017 Jun; 79(6):1096-1102. PubMed ID: 28496027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
